More than 20 years of protein expression work sits behind a service list spanning mammalian, baculovirus, BacMam, microbial and yeast platforms, plus PROTiQ protein design and de novo antibody design. Antibody offerings include IP-free stable cell line development, custom monoclonal antibody development and production, and hybridoma-to-recombinant conversion for legacy clones. Process work moves from process discovery and downstream purification into transient production and biomanufacturing at 1 to 100 liters in stirred-tank bioreactors, which lets clients characterize a process at diagnostic and pre-GMP scale before transferring it to a GMP facility, with cell banking available alongside. Analytical support covers affinity characterization by SPR and BLI and stability studies. Quality systems are certified to ISO 9001 and ISO 13485, with AAALAC accreditation covering animal work. Material is produced for human and veterinary biopharmaceuticals, vaccines and diagnostics. Kemp Proteins is a SIX.02 Bioservices company.

